Literature DB >> 2318977

Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

R J Hill1, M K Warren, J Levin.   

Abstract

To date, testing of various cytokines for the stimulation of blood cell production has not demonstrated a consistent effect on peripheral platelet levels. In this report, we provide evidence that human recombinant IL-6 increased platelet production in mice, as measured by both peripheral platelet levels and [75Se]selenomethionine (75SeM) incorporation into newly forming platelets. Peripheral white blood cell counts also were increased, but only to a modest extent, and hematocrit values were unchanged. A dose-response relationship between the amount of IL-6 administered and platelet count, 75SeM incorporation, and white blood cell count was demonstrated. Detectable megakaryocyte and granulocyte-macrophage colony-forming cells in mice that had received IL-6 also were increased in both bone marrow and spleen. These results demonstrate the ability of a purified, recombinant protein to stimulate platelet production in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318977      PMCID: PMC296558          DOI: 10.1172/JCI114559

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs.

Authors:  T R Ulich; J del Castillo; K Z Guo
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

2.  Comparative effects of thrombopoietic-stimulatory factor and spleen cell-conditioned medium on megakaryocytopoiesis in a short-term bone marrow liquid culture system.

Authors:  S R Petursson; P A Chervenick
Journal:  Exp Hematol       Date:  1988-09       Impact factor: 3.084

3.  Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia.

Authors:  T Hoang; A Haman; O Goncalves; G G Wong; S C Clark
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

4.  Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates.

Authors:  R E Donahue; J Seehra; M Metzger; D Lefebvre; B Rock; S Carbone; D G Nathan; M Garnick; P K Sehgal; D Laston
Journal:  Science       Date:  1988-09-30       Impact factor: 47.728

5.  Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat.

Authors:  J V Castell; T Geiger; V Gross; T Andus; E Walter; T Hirano; T Kishimoto; P C Heinrich
Journal:  Eur J Biochem       Date:  1988-11-01

6.  Functional discrimination between interleukin 6 and interleukin 1.

Authors:  M Helle; L Boeije; L A Aarden
Journal:  Eur J Immunol       Date:  1988-10       Impact factor: 5.532

7.  Effect of interleukin 6 (IL-6) on the differentiation and proliferation of murine and human hemopoietic progenitors.

Authors:  T Suda; Y Yamaguchi; J Suda; Y Miura; A Okano; Y Akiyama
Journal:  Exp Hematol       Date:  1988-12       Impact factor: 3.084

8.  Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat.

Authors:  M V Berridge; J K Fraser; J M Carter; F K Lin
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

9.  Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells.

Authors:  F J Bot; L van Eijk; L Broeders; L A Aarden; B Löwenberg
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

Review 10.  Clinical applications of recombinant human colony-stimulating factors.

Authors:  H G Klingemann
Journal:  CMAJ       Date:  1989-01-15       Impact factor: 8.262

View more
  20 in total

1.  Anemia in frailty.

Authors:  Cindy N Roy
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 2.  Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.

Authors:  K Yoshizaki; N Nishimoto; M Mihara; T Kishimoto
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.

Authors:  M Gupta; G J Noel; M Schaefer; D Friedman; J Bussel; R Johann-Liang
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

4.  Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis.

Authors:  E Unsal; S Aksaray; D Köksal; T Sipit
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

5.  Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of HST-1 (FGF-4) gene.

Authors:  H Konishi; T Ochiya; H Sakamoto; M Tsukamoto; I Saito; T Muto; T Sugimura; M Terada
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

6.  Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo.

Authors:  H Sakamoto; T Ochiya; Y Sato; M Tsukamoto; H Konishi; I Saito; T Sugimura; M Terada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy.

Authors:  H Bielefeldt-Ohmann; A L Marzo; R P Himbeck; A G Jarnicki; B W Robinson; D R Fitzpatrick
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

8.  Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.

Authors:  Elena Y Senchenkova; Shunsuke Komoto; Janice Russell; Lidiana D Almeida-Paula; Li-Sue Yan; Songlin Zhang; D Neil Granger
Journal:  Am J Pathol       Date:  2013-05-11       Impact factor: 4.307

9.  Effects of recombinant human interleukin 6 (rhIL-6) in marmosets (Callithrix jacchus). 1. General toxicity and hematological changes.

Authors:  S Klug; R Neubert; R Stahlmann; R Thiel; B Ryffel; B D Car; D Neubert
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Detection of IL-6 and its receptor mRNAs in a megakaryocytic cell line, CMK, by an RT-nested PCR.

Authors:  K Nakayama
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.